AIM ImmunoTech Inc. insider trading

AIMNYSE

$0.18-0.01 (-5.26% today)

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (-93.0%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Unlock quarterly net flow

Key players

TKThomas K. EquelsCEO & President0.4166%of company
TDTed D. KellnerDirector0.126%of company
DCDavid ChemerowDirector0.0934%of company
WMWilliam M. MitchellDirector0.0177%of company
PWPeter W. Rodino IIICOO, Secretary, Gen. Counsel0.0136%of company
SAStewart AppelrouthDirector0.0132%of company
NBNancy BryanDirector0.0099%of company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
AIM	Thomas K. EquelsCEO & President	Open market purchase$4.99K	+23.3%	$0.21	$4.99K	Sep 17, 2026	Sep 18, 2026
AIM	Thomas K. EquelsCEO & President	Open market purchase$2.31K	+12.0%	$0.21	$2.31K	Sep 16, 2026	Sep 17, 2026
AIM	Thomas K. EquelsCEO & President	Open market purchase$4.86K	+31.5%	$0.22	$4.86K	Sep 15, 2026	Sep 16, 2026
AIM	Thomas K. EquelsCEO & President	Open market purchase$1.29K	+9.2%	$0.22	$1.29K	Sep 14, 2026	Sep 15, 2026

End of history · 4 transactions